(Total Views: 177)
Posted On: 09/24/2019 8:53:54 PM
Post# of 36519
I like his articles, although I think some facts are off. Such as amount of shares in float pre and post dividend and that whole section. Also, AE doesn’t have a partnership with Merck “on similar footing “ as the one Immune Design had. Hopefully AE later wins that type of partnership when this study is positive.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)